Tell us about your case.
Trusted Counsel
Have you experienced discrimination due to MAT/MOUD while trying to access Rehabilitation services?
Kaplan & Grady has created the nation’s first practice group focused exclusively on fighting discrimination against people with opioid use disorder. This form of discrimination is not just a public health concern or a criminal justice issue. It is a pressing civil rights problem: substance use disorder is a disability protected under the Americans with Disabilities Act and other federal and state laws.
A major form of discrimination against people with opioid use disorder concerns access to medications like buprenorphine and methadone, which can mean the difference between life and death. Barriers to access often lead to intense withdrawal, pain and suffering, relapse, and overdoses.
Frequently Asked Questions
Nothing. We litigate these cases primarily on “contingency,” meaning that we do not get paid unless and until you do.
Absolutely, yes. Medications for opioid use disorder are the standard of care for many suffering from OUD, whether you are incarcerated or not.
You have a right not to be discriminated against for the medical treatment you require. Contact us to learn more and visit our resources page.
Tell us about your case.
Attorney Advertising
Topics Covered
What is Opioid Use Disorder?
Medications for Opioid Use Disorder
Legal Protections Related to Opioid Use Disorder
MOUD Resources
The Food and Drug Administration has approved three medications for treating opioid use disorder, also referred to as “MOUD.” The American Medical Association is clear that MOUD is the “standard of care for patients in jail and prison settings” and supports the removal of “administrative burdens or barriers that delay or deny care for FDA-approved medications used as part of medication assisted treatment (MAT) for opioid use disorder.”
Despite the broad consensus among medical experts and law enforcement organizations that MOUD are an essential medical treatment that saves lives, improves drug treatment results, and lowers criminal recidivism rates, entrenched stigma towards opioid use disorder generally and MOUD specifically continues to obstruct access to these life-saving medications.
